LOGIN  |  REGISTER
Cue Biopharma
Compass Therapeutics

Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign

May 21, 2024 | Last Trade: US$56.82 0.86 -1.49
  • The national initiative, Live Your PosSCZible, is focused on elevating the voices of those with schizophrenia and their care partners to drive impactful conversations about the aspirations of the community
  • Actor and author Taye Diggs and his sister, Christian, who was diagnosed with schizophrenia as a young adult, share their experiences alongside members of the schizophrenia community
  • Initiative provides resources and tools to increase the understanding of schizophrenia, reduce stigma, and promote empathy and support

PRINCETON, N.J. / May 21, 2024 / Business Wire / Bristol Myers Squibb (NYSE: BMY) today announced the launch of Live Your PosSCZible, a national campaign in partnership with the schizophrenia community focused on elevating lived experiences and empowering patients and care partners with educational, community and peer resources to help navigate care.

Schizophrenia is a persistent and often disabling mental illness impacting how a person thinks, feels and behaves, with onset typically occurring in late teens and early adulthood. When not properly managed, these symptoms can have a significant impact on daily functioning, overall quality of life, and can contribute to feelings of hopelessness. However, with appropriately managed symptoms and the right support, people with schizophrenia can achieve their ambitions.

“There is a persistent stereotype that people who live with schizophrenia are not able to lead meaningful and fulfilling lives, and that they have to put their professional and personal goals aside,” said Gordon Lavigne, CEO of the Schizophrenia & Psychosis Action Alliance. “This perception is false. With proper treatment and support, many people with schizophrenia can return to work or school, have a family, and enjoy friendships and social activities. The Live Your PosSCZible campaign tells stories of what is possible when you have access to proper treatment and care.”

The campaign elevates stories of the schizophrenia community, including the experiences of Broadway, television and movie actor and author, Taye Diggs, and his sister, Christian, who was diagnosed with schizophrenia as a young adult. Alongside Taye, the Live Your PosSCZible campaign will feature stories from care partners and people living with schizophrenia, including social media influencers and advocates, who share their personal experiences, how they manage daily challenges and their ambitions, all while encouraging others that it is possible for them too.

“When my sister was diagnosed with schizophrenia, my family was incredibly worried. At first, I couldn’t believe what I was hearing. So much of the information out there doesn’t accurately show what life with schizophrenia can be,” said Taye, known for his roles in Rent, Private Practice and All American. “But today, with support from medical professionals, my sister is managing her mental illness and is working and living independently, enjoys yoga and dance, and is doing really well. We want to get rid of the negative images many of us have of schizophrenia and raise awareness that people with schizophrenia can live full, happy lives.”

Stories from people living with schizophrenia and their care partners – as well as educational, community and peer resources to help navigate care – are available on the campaign website at LiveYourPosSCZible.com. The campaign also includes "Get Ready with Me” videos to showcase how different people with lived experience get ready for their planned activities and daily routines, taking inspiration from the #GRWM social media trend. Videos will launch at different times of the day across the campaign’s social media platforms on Instagram and TikTok, reflecting how people affected by schizophrenia often have varied schedules.

“A schizophrenia diagnosis can be extremely challenging. Not only do the symptoms of schizophrenia potentially impact all aspects of a person’s life, but society often tells them that their diagnosis means they have to put their goals aside,” said Jasmine Greenamyer, Vice President of Patient Outreach at Bristol Myers Squibb. “We launched Live Your PosSCZible to let people with schizophrenia know their ambitions are important and that with the right support, anything is possible.”

Learn more at LiveYourPosSCZible.com and follow Live Your PosSCZible on Instagram, TikTok and YouTube.

About Schizophrenia

Schizophrenia is a persistent and often disabling mental illness impacting how a person thinks, feels and behaves, and affects nearly 24 million people worldwide, including 2.8 million people in the U.S. It is characterized by three symptom domains: positive symptoms (hallucinations and delusions), negative symptoms (difficulty enjoying life and withdrawal from others) and cognitive impairment (deficits in memory, concentration, and decision-making).

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook and Instagram.

 

Recursion

Stock Quote

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB